Related Experiment Video
Updated: Jun 17, 2026
09:38
Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
Brain ERP components predict which individuals progress to Alzheimer's disease and which do not
Robert M Chapman1, John W McCrary, Margaret N Gardner
1Department of Brain and Cognitive Sciences and Center for Visual Science at the University of Rochester, Rochester, NY 14627, USA. rmc@cvs.rochester.edu
Neurobiology of Aging
|December 17, 2009
Summary
Predicting Alzheimer's disease (AD) progression in Mild Cognitive Impairment (MCI) is crucial. Brain Event-Related Potentials (ERPs) accurately identified individuals likely to develop AD, aiding early detection and intervention strategies.
Area of Science:
- Neuroscience
- Cognitive Science
- Biomarkers for Neurodegenerative Diseases
Background:
- Early prediction of Alzheimer's disease (AD) progression in Mild Cognitive Impairment (MCI) is vital for timely intervention and clinical trial stratification.
- Current methods for predicting AD progression from MCI have limitations in accuracy and specificity.
- Identifying reliable biomarkers is essential for advancing AD research and patient care.
Purpose of the Study:
- To investigate the utility of brain Event-Related Potentials (ERPs) in predicting the conversion of MCI to AD.
- To determine the accuracy, sensitivity, and specificity of ERP components in forecasting AD progression.
- To establish a predictive model using ERPs that provides individual likelihoods of progressing to Alzheimer's disease.
Main Methods:
- Utilized a perceptual/cognitive paradigm with varying processing demands to record brain Event-Related Potentials (ERPs) in individuals with MCI.
- Applied Principal Components Analysis (PCA) to identify and measure key ERP components, including P3 and memory-related potentials.
- Employed discriminant analysis with a weighted set of eight ERP component-conditions to predict AD progression, calculating posterior probabilities for each individual.
Main Results:
- A weighted set of eight ERP component-conditions demonstrated good accuracy, sensitivity, and specificity in predicting AD progression.
- The predictive model achieved 88% accuracy for individuals with high posterior probabilities (79% of the sample).
- Cross-validation yielded prediction accuracies between 70-78%, with empirical accuracies reaching 94% for individuals with posterior probabilities ≥ 0.90.
Conclusions:
- Brain Event-Related Potentials (ERPs) measured during a cognitive task serve as a valuable tool for predicting Alzheimer's disease progression in MCI patients.
- The developed ERP-based predictive model offers a reliable method for assessing individual likelihoods of converting to AD.
- This approach supports early identification of individuals at high risk for AD, facilitating personalized medicine and research advancements.
Related Concept Videos
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.